AfterRaise/Companies/IPercept Technology

IPercept Technology

IPercept Technology is an industrial physical AI and CNC machine diagnostics startup. From its funding announcement.

$16M Series ARaised yesterdayStockholm, SwedenHealthcare & MedtechSweden
Visit website →

In their own words

What IPercept Technology says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "industrial physical AI and CNC machine diagnostics startup". Source

Research and development

Public signal Read from the company's own description of what the funding supports.

Why now

Where IPercept Technology is today

IPercept Technology announced a Series A round of $16M on 30 September 2026, led by Isogon Ventures and 2150.

Latest round
Series A
Amount
$16M
Announced
30 September 2026
Headquarters
Stockholm, Sweden
Sector
Healthcare & Medtech
Investors
Also participating
Luminar Ventures, RunwayFBU, J12 Ventures, AI.Fund
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

67
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
12/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 30 September 2026
    $16M Series A
    Led by Isogon Ventures and 2150.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Research programme expansion
  • Scientific team growth
  • Repeatable go-to-market build
  • First senior commercial hires

Opportunities this could create

  • Scientific advisers
  • Research operations
  • Specialist suppliers
  • Clinical evidence
  • Regulatory affairs

Based on the Healthcare & Medtech sector, a Series A round and the priorities the company itself set out. Not a statement of fact.

Medium momentum2 connected signals
  • 30 September 2026$16M Series A announced
  • 30 September 2026Stated priority: research and development

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What IPercept Technology is open to

Not yet specified

IPercept Technology has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with IPercept Technology

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at IPercept Technology?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Healthcare & Medtech companies

See the sector